company background image
688687 logo

Beijing Kawin Technology Share-Holding SHSE:688687 Stock Report

Last Price

CN¥22.58

Market Cap

CN¥3.8b

7D

1.3%

1Y

-19.3%

Updated

15 Jul, 2024

Data

Company Financials +

Beijing Kawin Technology Share-Holding Co., Ltd.

SHSE:688687 Stock Report

Market Cap: CN¥3.8b

Beijing Kawin Technology Share-Holding Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beijing Kawin Technology Share-Holding
Historical stock prices
Current Share PriceCN¥22.58
52 Week HighCN¥37.63
52 Week LowCN¥18.50
Beta0.92
11 Month Change-20.97%
3 Month Change-8.43%
1 Year Change-19.27%
33 Year Change-18.78%
5 Year Changen/a
Change since IPO-46.24%

Recent News & Updates

We Think Beijing Kawin Technology Share-Holding (SHSE:688687) Can Stay On Top Of Its Debt

May 06
We Think Beijing Kawin Technology Share-Holding (SHSE:688687) Can Stay On Top Of Its Debt

Recent updates

We Think Beijing Kawin Technology Share-Holding (SHSE:688687) Can Stay On Top Of Its Debt

May 06
We Think Beijing Kawin Technology Share-Holding (SHSE:688687) Can Stay On Top Of Its Debt

Beijing Kawin Technology Share-Holding Co., Ltd. (SHSE:688687) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Mar 14
Beijing Kawin Technology Share-Holding Co., Ltd. (SHSE:688687) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Shareholder Returns

688687CN BiotechsCN Market
7D1.3%1.0%1.2%
1Y-19.3%-22.7%-18.5%

Return vs Industry: 688687 exceeded the CN Biotechs industry which returned -22.7% over the past year.

Return vs Market: 688687 matched the CN Market which returned -18.5% over the past year.

Price Volatility

Is 688687's price volatile compared to industry and market?
688687 volatility
688687 Average Weekly Movement7.0%
Biotechs Industry Average Movement6.4%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 688687's share price has been volatile over the past 3 months.

Volatility Over Time: 688687's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008584Desheng Zhouwww.kawin.com.cn

Beijing Kawin Technology Share-Holding Co., Ltd. engages in the development and production of pharmaceutical products primarily in the areas of liver diseases in China. The company’s products include recombinant human interferon alfa-2b injection; vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; and compound glycyrrhizin.

Beijing Kawin Technology Share-Holding Co., Ltd. Fundamentals Summary

How do Beijing Kawin Technology Share-Holding's earnings and revenue compare to its market cap?
688687 fundamental statistics
Market capCN¥3.78b
Earnings (TTM)CN¥117.53m
Revenue (TTM)CN¥1.43b

32.2x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688687 income statement (TTM)
RevenueCN¥1.43b
Cost of RevenueCN¥243.33m
Gross ProfitCN¥1.19b
Other ExpensesCN¥1.07b
EarningsCN¥117.53m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 10, 2024

Earnings per share (EPS)0.70
Gross Margin83.01%
Net Profit Margin8.21%
Debt/Equity Ratio5.9%

How did 688687 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

35%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.